Lack of causal relationship between leukocyte telomere length and coronary heart disease

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 375-380

  Cui, Guanglin ^a   Sun, Jing ^a   Zhang, Lina ^a   Li, Rui ^a   Wang, Yan ^a   Cianflone, Katherine ^b   Ding, Hu ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Coronary heart disease; Risk assessment; Telomere length; TERC

Indexed keywords

TELOMERASE; TELOMERASE RNA COMPONENT; UNCLASSIFIED DRUG; RNA; TELOMERASE RNA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; VERY ELDERLY; YOUNG ADULT; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BLOOD; CELL AGING; CHINA; CORONARY DISEASE; DNA SEQUENCE; EPIDEMIOLOGY; ETHNIC GROUP; GENETICS; LEUKOCYTE; OBSERVER VARIATION; RADIOGRAPHY; SINGLE BLIND PROCEDURE; TELOMERE HOMEOSTASIS; ULTRASTRUCTURE;

ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CAUSALITY; CELL AGING; CHINA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ETHNIC GROUPS; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; OBSERVER VARIATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA; SEQUENCE ANALYSIS, DNA; SINGLE-BLIND METHOD; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84896259375     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.008     Document Type: Article

References (31)

1. De Meyer T., Rietzschel E.R., De Buyzere M.L., et al. Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. Eur Heart J 2009, 30:3074-3081.
2. Serrano A.L., Andres V. Telomeres and cardiovascular disease: does size matter?. Circ Res 2004, 94:575-584.
3. Brouilette S.W., Moore J.S., McMahon A.D., et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007, 369:107-114.
4. Ding H., Chen C., Shaffer J.R., et al. Telomere length and risk of stroke in Chinese. Stroke 2012, 43:658-663.
5. van der Harst P., van der Steege G., de Boer R.A., et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. JAm Coll Cardiol 2007, 49:1459-1464.
6. Weischer M., Bojesen S.E., Cawthon R.M., et al. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol 2012, 32:822-829.
7. Codd V., Mangino M., van der Harst P., et al. Common variants near TERC are associated with mean telomere length. Nat Genet 2010, 42:197-199.
8. Saliques S., Zeller M., Lorin J., et al. Telomere length and cardiovascular disease. Arch Cardiovasc Dis 2010, 103:454-459.
9. Xu Y., Ding H., Peng J., et al. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease. Pharmacogenet Genomics 2011, 21:489-494.
10. Ding H., Wu B., Wang H., et al. Anovel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res 2010, 106:1145-1152.
11. Montorsi P., Ravagnani P.M., Galli S., et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006, 27:2632-2639.
12. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47.
13. Didelez V., Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 2007, 16:309-330.
14. Thomas D.C., Lawlor D.A., Thompson J.R. Re: estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista etal. Ann Epidemiol 2007, 17:511-513.
15. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. Br Med J 2003, 326:219.
16. Prescott J., Kraft P., Chasman D.I., et al. Genome-wide association study of relative telomere length. PLoS One 2011, 6:e19635.
17. Levy D., Neuhausen S.L., Hunt S.C., et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci U S A 2010, 107:9293-9298.
18. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55:876-882.
19. Vasa-Nicotera M., Brouilette S., Mangino M., et al. Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 2005, 76:147-151.
20. Shen Q., Zhang Z., Yu L., et al. Common variants near TERC are associated with leukocyte telomere length in the Chinese Han population. Eur J Hum Genet 2011, 19:721-723.
21. Hara Y., Yamagata K., Oguchi K., et al. Nuclear localization of profilin III-ArpM1 complex in mouse spermiogenesis. FEBS Lett 2008, 582:2998-3004.
22. Rabenau K.E., O'Toole J.M., Bassi R., et al. DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene 2004, 23:5056-5067.
23. Njajou O.T., Blackburn E.H., Pawlikowska L., et al. Acommon variant in the telomerase RNA component is associated with short telomere length. PLoS One 2010, 5:e13048.
24. Ross R. Atherosclerosis-an inflammatory disease. NEngl J Med 1999, 340:115-126.
25. Andrew T., Aviv A., Falchi M., et al. Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 2006, 78:480-486.
26. Spyridopoulos I., Hoffmann J., Aicher A., et al. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity. Circulation 2009, 120:1364-1372.
27. Mainous A.G., Codd V., Diaz V.A., et al. Leukocyte telomere length and coronary artery calcification. Atherosclerosis 2010, 210:262-267.
28. Samani N.J., Boultby R., Butler R., et al. Telomere shortening in atherosclerosis. Lancet 2001, 358:472-473.
29. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci 2000, 908:99-110.
30. Harrison D. Oxidative stress and coronary artery disease. Can J Cardiol 1998, 14(Suppl.D):30D-32D.
31. Wong L.S., Huzen J., van der Harst P., et al. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure. Eur J Heart Fail 2010, 12:348-353.